Literature DB >> 10338877

Prescription drug product labeling; medication guide requirements--FDA. Final rule.

.   

Abstract

The Food and Drug Administration (FDA) is establishing requirements for the distribution of patient labeling for selected prescription human drug and biological products used primarily on an outpatient basis. The agency is requiring the distribution of patient labeling, called Medication Guides, for certain products that pose a serious and significant public health concern requiring distribution of FDA-approved patient medication information. The intent of this action is to improve public health by providing information necessary for patients to use their medications safely and effectively. FDA believes that this program will result in direct improvements in the safe and effective use of prescription medications.

Entities:  

Mesh:

Year:  1998        PMID: 10338877

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  3 in total

1.  Usability of FDA-approved medication guides.

Authors:  Michael S Wolf; Jennifer King; Elizabeth A H Wilson; Laura M Curtis; Stacy Cooper Bailey; James Duhig; Allison Russell; Ashley Bergeron; Amanda Daly; Ruth M Parker; Terry C Davis; William H Shrank; Bruce Lambert
Journal:  J Gen Intern Med       Date:  2012-05-08       Impact factor: 5.128

2.  Neuropsychiatric Adverse Reactions to Mefloquine: a Systematic Comparison of Prescribing and Patient Safety Guidance in the US, UK, Ireland, Australia, New Zealand, and Canada.

Authors:  Remington L Nevin; Aricia M Byrd
Journal:  Neurol Ther       Date:  2016-05-30

3.  Patients' ability to read and understand dosing instructions of their own medicines - a cross sectional study in a hospital and community pharmacy setting.

Authors:  M G C A Manchanayake; G R W S K Bandara; N R Samaranayake
Journal:  BMC Health Serv Res       Date:  2018-06-07       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.